ABL Supporting Manufacture of AlphaCore's rhLCAT Protein through NHLBI's SMARTT Program
Feb 14, 2012
Ann Arbor, MI and Rockville, MD [February 14, 2012] - AlphaCore Pharma, a biopharmaceutical company, and Advanced Bioscience Laboratories (ABL), a biomedical contract research and manufacturing company, today announce funding [ READ MORE ]
Inviragen Enlists ABL for Manufacture of Master Virus Seed Stock for Plague Vaccine Development
Feb 08, 2012
FORT COLLINS, CO and ROCKVILLE, MD – February 8, 2012 – [ READ MORE ]
ABL Exhibiting at the IBC Biopharmaceutical Development and Production Week in San Diego
Jan 16, 2012
Feb. 27 – Mar. 4, 2012
[ READ MORE ]Trophogen Selects ABL as Contract Manufacturer for Recombinant, Human Follicle-Stimulating Hormone (rhFSH) Analog
Jan 10, 2012
Rockville, MD (January 10, 2012) – Trophogen Inc., a biotechnology company developing hormone and related growth factor analogs [ READ MORE ]
ABL Display at Phacilitate in Washington, D.C. Jan.30-Feb.1
Jan 10, 2012
For more information on ABL's capabilities and partnering opportunities, contact info@ablinc.com.
[ READ MORE ]
